PFE Stock Price - Pfizer Inc - (PFE)
- Prev. Close: 33.53
- Open: 33.56
- Daily Range: 33.41 - 33.86
PFE NEWS FROM BIDNESS ETC
Here’s How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...
Pfizer has agreed to buy two meningitis vaccines from GlaxoSmithKline for $130 million
Merck & Co., GlaxoSmithKline plc, & Others Expected To Be Neck-And-...
A report compiled by EvaluatePharma’s analysts estimates that the vaccines market will be stiff with competition by 2020. Here’s the breakup
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche Ho...
New rumors from UK traders, reported by Daily Mail UK, suggest Johnson & Johnson and Roche Holding as possible bidders for GSK
- Pfizer Inc. (PFE) To Boost Production In China With $95 Million Plant
- Insider Selling: Pfizer Inc. (PFE), Goldman Sachs Group Inc (GS), Celgene C...
- Pfizer Inc. Wards Off Another Birth Defect Case Against Antidepressant Zolo...
- Pfizer Inc. Still In Trouble Over Anti-depressant Drug Zoloft And Birth Def...
- Insider Selling: Pfizer Inc. (PFE), Anthem Inc (ANTM), And CVS Health Corp ...
- Pfizer Inc. (PFE) Split Could Be Announced By 2015-2016: JPMorgan
- Pfizer Inc. Interested In Acquiring French Biotech Firm Cellectis SA (ADR) ...
- Pfizer Inc. Gets FDA Green Signal For The First Drug To Treat A Rare Lung D...
- Driven By Pfizer Inc. And Novartis AG (ADR), Global Breast Cancer Drug Sale...
More News From Bidness
Pfizer Inc. Mega-Merger Talk: The Speculated Targets PUBLISHED: May 22, 2015 at 8:04 am ESTPfizer Inc.-GlaxoSmithKline Merger Talk: Deutsche Bank ... PUBLISHED: May 21, 2015 at 8:02 am ESTPfizer Inc. To See Boosting Revenues On New Drugs Growt... PUBLISHED: May 20, 2015 at 11:29 am ESTInhaled Insulin: How MannKind Corporation Can Make It W... PUBLISHED: May 18, 2015 at 6:37 am EST
Early ORR For Pfizer (PFE) And Merck’s (MRK) Avelumab In Lung Is Unimpressive: SunTrust PUBLISHED: May 14, 2015 at 10:14 am EST
Pfizer Inc., Merck KGaA (ADR) To Set Strong Foothold In Cancer Immunotherapy Drugs Market PUBLISHED: May 14, 2015 at 10:14 am EST
The fast-expanding class of immunotherapy drugs presents a high-growth opportunity for both Pfizer and Merck KGaA. If tapped into at the right time, the market can yield high revenues for both parties in the long runREAD MORE
Biogen Inc (BIIB) May Soon Trump Pfizer In Global CNS Drug Sales PUBLISHED: May 13, 2015 at 6:23 am EST
Biogen saw 46% growth in global central nervous system drug sales in 2014, coming almost neck-and-neck with Pfizer, as per GlobalDataREAD MORE
Pfizer Inc. (PFE) Attains Stake In AM-Pharma; Locks In Right To Buy Whole Company PUBLISHED: May 12, 2015 at 8:24 am EST
Pzifer has acquired a minority stake in AM-Pharma and has also gained the exclusive option to acquire the whole companyREAD MORE
Pfizer Inc. May Soon Become A Successful Turnaround Story PUBLISHED: May 8, 2015 at 6:30 am EST
Pfizer may be at the cusp of a turnaround, as it has many potential blockbuster drugs in its pipeline that can reverse the trend of revenue decline at the companyREAD MORE
Driven By Amgen, Inc. (AMGN) And Novartis AG Drugs, Sales For ALL Treatment Drugs Expected To Double By 2020 PUBLISHED: May 5, 2015 at 2:53 pm EST
Analysts are expecting sales from acute lymphocytic leukemia drugs to more than double by 2020, due to the better and advanced drugs being developed by drugmakers like Amgen and NovartisREAD MORE
Pfizer Inc. (PFE) China Sales Boosted As Viagra Gains Demand PUBLISHED: May 4, 2015 at 11:38 am EST
Pfizer’s revenues from its mature drugs in China rose as much as 18% YoY last year, and are expected to contribute even more to the company’s overall sales this yearREAD MORE